ArticleNature communications2025

Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.

Martina Mang Leng Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.